Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437318
Brief Title: Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. (SOLAR-1)

First Submitted : April 22, 2015
First Submitted that Met QC Criteria : May 4, 2015
First Posted : May 7, 2015 (Estimate)

Results First Submitted : June 17, 2019
Results First Submitted that Met QC Criteria : July 22, 2019
Results First Posted : August 13, 2019

Certification/Extension First Submitted : July 24, 2018
Certification/Extension First Submitted that Met QC Criteria : July 24, 2018
Certification/Extension First Posted : July 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : November 10, 2019
Last Update Posted : November 20, 2019